Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ADCT
$1.01
-3.81%
ADCT · ADC Therapeutics SA
$1.01
-0.04 (-3.81%)
At close · Aug 14
Market Cap
$128.94M
Shares
127.67M
All earnings calls
Earnings call · FY2026 Q2
ADC Therapeutics SA Q2 FY2026 Earnings Call
ADC Therapeutics SA Q2 FY2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$19.25M
+2.2% YoY
Diluted EPS
-$0.11
Net income
-$16.57M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 13, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Annualized estimated cost savings
from the reorganization
|
$10M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document